Infections due to non-O1 Vibrio cholerae in southern Taiwan: Predominance in cirrhotic patients

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 774-780

  Ko, Wen Chien ^a   Chuang, Yin Ching ^b   Huang, Guang Chang ^b   Hsu, Shiu Yuan ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MINOCYCLINE; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIMENTIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; CELLULITIS; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROENTERITIS; HUMAN; LIVER CIRRHOSIS; MALE; NECROTIZING FASCIITIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGITIS; SOFT TISSUE INFECTION; VIBRIO CHOLERAE; VIBRIO VULNIFICUS;

EID: 2442738572     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514947     Document Type: Article

References (26)

1. Kay BA, Bopp CA, Wells JG. Isolation and identification of Vibrio cholerae O1 from fecal specimens. In: Wachsmuth K, Blake PA, Olsvik O, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994:3-25.
2. Morris JG Jr. Non-O group 1 Vibrio cholerae strains not associated with epidemic disease. In: Wachsmuth K, Blake PA, Olsvik O, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994:103-15.
3. Safrin S, Morris JG Jr, Adams M, Pons V, Jacobs R, Conte JE Jr. Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis 1988; 10:1012-7.
4. Morris JG Jr. Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol Rev 1990; 12:179-91.
5. Pitrak DL, Gindorf JD. Bacteremic cellulitis caused by non-serogroup O1 Vibrio cholerae acquired in a freshwater inland lake. J Clin Microbiol 1989; 27:2874-6.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test: approved standard. 6th ed. NCCLS document M2-A6. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
7. McLaughlin JC. Vibrio. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995:465-76.
8. Dhar R, Ghafoor MA, Nasralah AY. Unusual non-serogroup O1 Vibrio cholerae bacteremia associated with liver disease. J Clin Microbiol 1989; 27:2853-5.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-9.
10. Lin CJ, Chiu CT, Lin DY, Sheen IS, Lien JM. Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center. Am J Gastroenterol 1996; 91:336-40.
11. Halabi M, Haditsch M, Renner F, Brinninger G, Mittermayer H. Vibrio cholerae non-O1 septicemia in a patient with liver cirrhosis and Brillroth-II-gastrectomy. J Infect 1997; 34:83-4.
12. Chuang YC, Yuan CY, Liu CY, Lan CK, Huang AHM. Vibrio vulnificus infections in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 1992; 15:271-6.
13. Clark R, Bracy W, Hanna B, Love GL. Case report: Vibrio cholerae non-O1 infection presenting as localized cellulitis. Am J Med Sci 1989; 298: 328-30.
14. Lee MH, Leu HS, Huang SH. Bacteremic cellulitis caused by non-O1 Vibrio cholerae: report of a case. J Formos Med Assoc 1993; 92: 472-4.
15. Chan HL, Ho HC, Kuo TT. Cutaneous manifestation of non-O1 Vibrio cholerae septicemia with gastroenteritis and meningitis. J Am Acad Dermatol 1994; 30:626-8.
16. Kontoyiannis DP, Calia KE, Basgoz N, Calderwood SB. Primary septicemia caused by Vibrio cholerae non-O1 acquired on Cape Cod, Massachusetts. Clin Infect Dis 1995; 21:1330-3.
17. Howard RJ, Bennett NT. Infections caused by halophilic marine Vibrio bacteria. Ann Surg 1993; 217:525-31.
18. Magnusson MR, Pegg SP. Vibrio cholerae non-O1 primary septicemia following a large thermal bum. Burns 1996; 22:44-7.
19. Thomas M, Cherian T, Raghupathy P. Non-O:1 Vibrio cholerae bacteremia and peritonitis in a patient with nephrotic syndrome [letter]. Pediatr Infect Dis J 1996; 15:276-7.
20. Blanche P, Sicard D, Sevali Garcia J, Paul G, Fournier JM. Septicemia due to non-O:1 Vibrio cholerae in a patient with AIDS [letter]. Clin Infect Dis 1994; 19:813.
21. Andersen BR. Host factors causing increased susceptibility to infection in patients with Laennec's cirrhosis. Ann NY Acad Sci 1975; 252: 348-52.
22. Sciortino CV, Johnson JA, Hamad A. Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae. J Clin Microbiol 1996; 34:897-900.
23. Chuang YC, Liu JW, Ko WC, Lin KY, Wu JJ, Huang KY. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother 1997; 41:2214-7.
24. Chuang YC, Ko WC, Wang ST, et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 1998; 42:1319-22.
25. Morris JG Jr, Wilson R, Davis BR, et al. Non-O group 1 Vibrio cholerae gastroenteritis in the United States. Ann Intern Med 1981; 94:656-8.
26. Hoge CW, Watsky D, Peeler RN, Libonati JP, Israel E, Morris JG Jr. Epidemiology and spectrum of vibrio infections in a Chesapeake Bay community. J Infect Dis 1989; 160:985-93.